Suppr超能文献

三甲胺尿症:一种社交困扰性疾病的病因与诊断

Trimethylaminuria: causes and diagnosis of a socially distressing condition.

作者信息

Mackay Richard J, McEntyre Christopher J, Henderson Caroline, Lever Michael, George Peter M

机构信息

Biochemistry Unit and.

出版信息

Clin Biochem Rev. 2011 Feb;32(1):33-43.

Abstract

Trimethylaminuria is a disorder in which the volatile, fish-smelling compound, trimethylamine (TMA) accumulates and is excreted in the urine, but is also found in the sweat and breath of these patients. Because many patients have associated body odours or halitosis, trimethylaminuria sufferers can meet serious difficulties in a social context, leading to other problems such as isolation and depression. TMA is formed by bacteria in the mammalian gut from reduction of compounds such as trimethylamine-N-oxide (TMAO) and choline. Primary trimethylaminuria sufferers have an inherited enzyme deficiency where TMA is not efficiently converted to the non-odorous TMAO in the liver. Secondary causes of trimethylaminuria have been described, sometimes accompanied by genetic variations. Diagnosis of trimethylaminuria requires the measurement of TMA and TMAO in urine, which should be collected after a high substrate meal in milder or intermittent cases, most simply, a marine-fish meal. The symptoms of trimethylaminuria can be improved by changes in the diet to avoid precursors, in particular TMAO which is found in high concentrations in marine fish. Treatment with antibiotics to control bacteria in the gut, or activated charcoal to sequester TMA, may also be beneficial.

摘要

三甲胺尿症是一种病症,其中挥发性的、有鱼腥味的化合物三甲胺(TMA)会蓄积并经尿液排出,不过在这些患者的汗液和呼吸中也能检测到。由于许多患者伴有体臭或口臭,三甲胺尿症患者在社交场合会遇到严重困难,进而引发如孤立和抑郁等其他问题。TMA由哺乳动物肠道中的细菌通过还原三甲胺-N-氧化物(TMAO)和胆碱等化合物形成。原发性三甲胺尿症患者存在遗传性酶缺乏,导致TMA在肝脏中无法有效转化为无气味的TMAO。已描述了三甲胺尿症的继发性病因,有时还伴有基因变异。三甲胺尿症的诊断需要检测尿液中的TMA和TMAO,在症状较轻或间歇性发作的情况下,应在摄入高底物餐(最简单的是海鱼餐)后收集尿液。通过改变饮食以避免摄入前体物质,特别是海鱼中高浓度存在的TMAO,可改善三甲胺尿症的症状。使用抗生素控制肠道细菌或用活性炭螯合TMA进行治疗可能也有益处。

相似文献

9
Impact of trimethylaminuria on daily psychosocial functioning.三甲胺尿症对日常心理社会功能的影响。
JIMD Rep. 2020 Oct 6;57(1):67-75. doi: 10.1002/jmd2.12170. eCollection 2021 Jan.

引用本文的文献

10
Advancing rare disease policy in Latin America: a call to action.推动拉丁美洲的罕见病政策:行动呼吁。
Lancet Reg Health Am. 2023 Jan 27;18:100434. doi: 10.1016/j.lana.2023.100434. eCollection 2023 Feb.

本文引用的文献

3
A physiological role for flavin-containing monooxygenase (FMO3) in humans?
Xenobiotica. 2010 May;40(5):301-5. doi: 10.3109/00498251003702753.
8
Flavin-containing monooxygenases: mutations, disease and drug response.含黄素单加氧酶:突变、疾病与药物反应。
Trends Pharmacol Sci. 2008 Jun;29(6):294-301. doi: 10.1016/j.tips.2008.03.004. Epub 2008 Apr 16.
10
Mechanisms regulating human FMO3 transcription.调节人类FMO3转录的机制。
Drug Metab Rev. 2007;39(2-3):419-42. doi: 10.1080/03602530701498612.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验